Could a common diabetes drug help manage gestational diabetes?
NCT ID NCT05482789
First seen Jan 09, 2026 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This pilot study is testing how exenatide, an FDA-approved drug for type 2 diabetes, works in pregnant women with gestational diabetes. Researchers want to see how the body processes the drug and how well it controls blood sugar after a meal. Only 13 women will take part, and the goal is to see if exenatide could be a helpful addition to current treatments like insulin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Magee Womens Hospital of UPMC
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Exenatide (a diabetes drug injected under the skin)
What this could lead to
If it works, this could point toward a new treatment option for gestational diabetes when standard therapies are not enough.
What could go wrong
This is a very small pilot study with only 13 participants, so results may not apply widely. Exenatide is not yet proven safe or effective in pregnancy, and side effects like nausea are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.